Publish date: March, 2011 Code: M2910 Language: English Pages: ca. 556 Price: from 1290 Euro Download: Sample reading Order form

Abstract

When other major application markets of technical ceramics slumped during the global economic downturn, medical ceramics market sustained positive growth benefiting from the robust medical devices market.

Publish date: February, 2010 Code: M2710 Language: English Pages: ca. 550 Price: from 1190 Euro Download: Sample reading Order form

Abstract

Biomedical metal market enjoys well above industry average growth, benefiting from robust growth in the application markets such as orthopaedic implant, cardiac/vascular implant, etc. The advancements in biomaterials in turn massively boost the development of the biomedical devices industry.

Publish date: March, 2008 Code: C4630 Language: English Pages: ca. 580 Price: from 1190 Euro Download: Sample reading Order form

Abstract

The world pharmaceutical fine chemicals market in 2006 was valued at approximately US$ 61.1 billion. It enjoys a much better market prospect than other fine chemical industries, with ca. 2% plus higher growth rate. Its global sales was estimated at US$ 65.23 billion in 2007, and is expected to reach US$ 77 billion by 2010 and increase to US$ 106 billion by 2015. It is a changing market with opportunities and risks such as niche technology, emerging markets, overcapacity, stricter regulations and heavier competition.

Publish date: September, 2007 Code: M2500 Language: English Price: from 990 Euro Download: Sample reading Order form

Abstract

Demand for medical devices grows faster than expected in recent years. World market totalled $209 billion in 2006, and is projected to grow with an average annual rate of 6-9% through 2010. Medical device is a highly dynamic industry, where dramatic innovations and developments are taking place every day. Driven by both the increasing demand in overseas markets and companies' ambition to pursue profit globally, the globalization of medical device industry is intensified. So is the need to understand the global market.

Publish date: In updating
Code: M2620
Language: English
Price: 2950 Euro

Abstract

With the market size of over US$ 80 billion in 2004, the United States accounts for more than 40 percent of the global sales, some segments representing even more than half of the world market. As the baby-boom generation enters their retirement age, the demand on advanced medical devices pushes the technology innovations and market forward. The US market is expected to grow at a compound annual rate of 6-8% through 2010, despite government measures of cost containment.

Publish date: In updating
Code: M2610
Language: English
Price: 2950 Euro

Abstract

The European market of medical devices slowed down in recent years and is faced with great restructuring because of stagnated economy and government efforts of health care cost containment. The sales of 2004 in EU was valued at over US$60 billion, with Germany, France, UK, Italy and Spain accounting for more than two 70% of the total market. Despite a variety of problems, the West Europe will remain a leading industry base and innovation source of medical devices and technologies in the future years. Surgical instruments, optical devices, imaging equipments and etc. are their leading competitive product lines.

Publish date: In updating
Code: M2520
Language: English
Price: 2950 Euro

Abstract

The global market for in vitro diagnostic tests was valued at US$23.56 in 2004, and anticipated to grow with average annual rate of 6% through 2010. With the introduction of new technologies to IVD tests and IVD systems, the traditional industry is being developed for a much wider range of applications. In addition to infectious diseases, chronic diseases such as diabetes and cardiovascular diseases are gaining importance in IVD tests. The IVD market grows with the growing population of target patients.

Publish date: In updating
Code: M2510
Language: English
Price: 2950 Euro

Abstract

Although the oldest segment of medical device industry, surgical devices and instruments comprises a market of more than US$40 billion in 2004, 7.6% up from 2003. This market is expected to continue to grow fast with high potential. While the traditional surgical instrument experiences relatively slow yet steady growth in last years, the phenomenal growth of minimal invasive surgical technology is transforming the landscape of the surgical instrument marketplace, and triggered a new round of innovation in this branch.

Publish date: May, 2007
Code: P1510
Language: English
Price: 2950 Euro

Abstract

The cancer market is the third largest among the pharmaceutical industry, following cardiovascular and central nervous system therapeutic categories. As cancer is one of the leading causes for deaths, comprehensive research has been carried out to develop new drugs and methods for its prevention, diagnosis, treatment and cure.

Publish date: November, 2006
Code: P1630
Language: English
Price: 2950 Euro

Abstract

As the second largest in Asia, China's medical devices market was estimated at approximately US$6 billion in 2004, up 16% from US$5.3 billion in 2003. Under current economic development, the China's medical devices market will continue to grow with double digit growth rate through the next decade.

Publish date: August, 2006
Code: P1620
Language: English
Price: 2950 Euro

Abstract

The US is the largest and wealthiest market for pharmaceuticals as well as the most important research and development base for pharma industry in the world. The drug sales reached a historical high of US$245 billion in 2004, up 10% from 2003, a lowest year-over-year growth in the last five years. The main factors which suppress the US pharma market growth include generic erosion, OTC switches, and lower government approval of new drugs. Yet driven by increasing aging population and changing lifestyle, the US will still be a strong and robust market for pharmaceuticals.

Publish date: May, 2006
Code: P1610
Language: English
Price: 2950 Euro

Abstract

The European pharmaceutical market is currently hampered by the overall sluggish economy and the government measures to limit pharmaceutical expenditures. The sales grew 6% to reach 165 in 2004, and are predicted to even slow down to 5% over the next two years as the economy stagnates. While the aging population, earlier diagnosis and recognition of diseases, accession to previously untapped patient groups are strong drivers to push the whole market forward.

Publish date: August, 2006
Code: P1520
Language: English
Price: 2950 Euro

Abstract

The global sales of cardiovascular medications are expected to surpass US$120 billion by 2006, from US$91 billion in 2003. Among this largest therapeutic category in terms of market size, the segment of anti-hypertension alone comprises a current market of US$33 billion, and is to increase with a double-digit AAGR through 2010 driven by the rapidly growing aging population in industrial countries. Cardiovascular disease will continue to remain a focus of the pharmaceutical industry.

Publish date: Feburary, 2006 Code: P1500 Language: English Pages: 326 Price: 2950 Euro

Abstract

Although affected by heavier governmental regulations and cost containment measures, the world pharmaceutical industry still achieved good performance in 2004 with the total sales of $490 billion, at a rate of 8.6% from 2003. Because of government policy uncertainties, the overall pharma industry will continue to face difficulties in the coming years. Yet the industry is still projected to experience near double-digit growth, boosted by the combination of population and lifestyle changes, the huge unmet needs and emerging markets in developing countries.